CLDN5 and schizophrenia: Fourth, multiple sclerosis (MS) is a neurodegenerative disease showing increased CLDN-5 levels [44], whereas major depressive disorder and schizophrenia are psychiatric disorders associated with increased and decreased plasma and serum CLDN-5 levels, respectively [45,46].